Tumor growth pattern and thymidine phosphorylase expression are related with the risk of hematogenous metastasis in patients with Astler Coller B1/B2 colorectal carcinoma

Cancer

Volumn 91, Issue 9, 2001, Pages 1752-1757

  Van Halteren, Henk K ^a,d   Peters, Herman M ^b   Van Krieken, J Han J M ^a   Coebergh, Jan Willem W ^b   Roumen, Rudi M H ^a,c   Van Der Worp, Erik ^d   Wagener, J Theo ^c   Vreugdenhil, Gerard ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Regional Laboratory of Pathology   (Netherlands)

^c The Netherlands   (Netherlands)

^d ST JOSEPH HOSPITAL   (Netherlands)

Author keywords

Colorectal carcinoma; Growth pattern; Recurrence risk; Thymidine phosphorylase

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; TUMOR GROWTH;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HEMATOLOGIC NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035339895     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010501)91:9<1752::AID-CNCR1194>3.0.CO;2-M     Document Type: Article

References (38)

1. Carcinoma of the colon and rectum: The natural history reviewed in 1704 patients
2. Failure patterns following curative resection of colonic carcinoma
3. For patients with Dukes B colorectal carcinoma examination of six or fewer lymph nodes is related to a poor prognosis
4. Colorectal adenocarcinoma: Quality of the assessment of lymph node metastasis
5. Lymph node harvest reporting in patients with carcinoma of the large bowel
6. Prognostic significance of perirectal lymph node micrometastases in Dukes B rectal carcinoma: An immunohistochemical study by CAM 5.2
7. Clinical implications of lymph node micrometastases in patients with colorectal cancer
8. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes B colorectal carcinoma: An immunohistochemical study
9. Micrometastases and survival in stage II colorectal cancer
10. Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers
11. A new prognostic classification of rectal cancer
12. Jass' classification revisited
13. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer
14. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma
15. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma
16. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with a ductal adenocarcinoma of the pancreas
17. Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast
18. Thymidine phosphorylase in human esophageal squamous cell carcinoma
19. The activity and expression of thymidine phosphorylase in human solid tumors
20. Clinicopathologic and prognostic significance of an angiogenic factor thymidine phosphorylase in human colorectal carcinoma
21. Expression of platelet-derived endothelian cell growth factor with good prognosis in patients with colorectal carcinoma
22. Purification and properties of an endothelian cell growth factor from human platelets
23. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelian cell growth factor
24. Thymidine phosphorylase activity associated with platelet-derived endothelian cell growth factor
25. Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous carcinoma and their different characteristics
26. Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas
27. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas
28. Prevention of hypoxia-induced apoptosis by the angiogenic thymidine phosphorylase
29. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer
30. Combined analysis of P53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
31. Tumor angiogenesis as a prognostic indicator in colorectal carcinoma with special reference to mode of metastasis and recurrence
32. Angiogenesis as an unfavourable prognostic factor in human colorectal carcinoma
33. Prognostic significance of the microvascular count in colorectal cancer
34. Prospective study of intratumoral microvessel density, P53 expression and survival in colorectal cancer
35. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma
36. P53 immunoreaction in endoscopic biopsy specimens of colorectal cancer and its prognostic significance
37. P53 point mutation and survival in colorectal cancer patients
38. Ki-ras mutation and p53 overexpression predict the clinical behaviour of colorectal cancer: A Southwest Oncology Group Study